[go: up one dir, main page]

ES474693A1 - Procedimiento para la preparacion de 9-(w-heteroarilamino-alcohilamino)-eritromicinas. - Google Patents

Procedimiento para la preparacion de 9-(w-heteroarilamino-alcohilamino)-eritromicinas.

Info

Publication number
ES474693A1
ES474693A1 ES474693A ES474693A ES474693A1 ES 474693 A1 ES474693 A1 ES 474693A1 ES 474693 A ES474693 A ES 474693A ES 474693 A ES474693 A ES 474693A ES 474693 A1 ES474693 A1 ES 474693A1
Authority
ES
Spain
Prior art keywords
pyrimidinyl
heteroarilamino
eritromicinas
alcohilamino
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES474693A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH and Co KG
Original Assignee
Dr Karl Thomae GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Karl Thomae GmbH filed Critical Dr Karl Thomae GmbH
Publication of ES474693A1 publication Critical patent/ES474693A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

Nuevas 9-(omega-heteroarilamino-alcohilamino)-eritromicinas de la fórmula general I R - NH - (CH2)n - NH - E (I) a sus sales por adición de ácido farmacológicamente compatibles con ácidos orgánicos o inorgánicos, a un procedimiento para la preparación de estos compuestos, y a medicamentos que contienen estos compuestos. En la fórmula general I antedicha: E significa el grupo eritromicilo, + **(Fórmula)**
ES474693A 1977-11-10 1978-10-31 Procedimiento para la preparacion de 9-(w-heteroarilamino-alcohilamino)-eritromicinas. Expired ES474693A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19772750288 DE2750288A1 (de) 1977-11-10 1977-11-10 Neue 9-(omega-heteroarylamino- alkylamino)-erythromycine, ihre salze, verfahren zu ihrer herstellung und diese enthaltende arzneimittel

Publications (1)

Publication Number Publication Date
ES474693A1 true ES474693A1 (es) 1979-04-01

Family

ID=6023435

Family Applications (1)

Application Number Title Priority Date Filing Date
ES474693A Expired ES474693A1 (es) 1977-11-10 1978-10-31 Procedimiento para la preparacion de 9-(w-heteroarilamino-alcohilamino)-eritromicinas.

Country Status (18)

Country Link
US (1) US4256738A (es)
EP (1) EP0001981B1 (es)
JP (1) JPS5476588A (es)
AT (1) AT361623B (es)
AU (1) AU4144878A (es)
CA (1) CA1107726A (es)
DE (2) DE2750288A1 (es)
DK (1) DK499778A (es)
ES (1) ES474693A1 (es)
FI (1) FI783417A7 (es)
GR (1) GR65281B (es)
IL (1) IL55906A0 (es)
IT (1) IT1109331B (es)
NO (1) NO783767L (es)
NZ (1) NZ188872A (es)
PT (1) PT68771A (es)
YU (1) YU261178A (es)
ZA (1) ZA786313B (es)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2473525A1 (fr) * 1980-01-11 1981-07-17 Roussel Uclaf Nouvelles oximes derivees de l'erythromycine, leur procede de preparation et leur application comme medicaments
US5110800A (en) * 1986-02-18 1992-05-05 Eli Lilly And Company Derivatives of erythromycylamine
US5075289A (en) * 1988-06-07 1991-12-24 Abbott Laboratories 9-r-azacyclic erythromycin antibiotics
US5958934A (en) * 1996-05-23 1999-09-28 Syntex (U.S.A.) Inc. Aryl pyrimidine derivatives and uses thereof
US5952331A (en) * 1996-05-23 1999-09-14 Syntex (Usa) Inc. Aryl pyrimidine derivatives
TW440563B (en) * 1996-05-23 2001-06-16 Hoffmann La Roche Aryl pyrimidine derivatives and a pharmaceutical composition thereof
US5739127A (en) * 1996-11-08 1998-04-14 Bayer Aktiengesellschaft 2,4'-bridged bis-2,4-diaminoquinazolines
WO2003001887A2 (en) * 2001-06-28 2003-01-09 Essential Therapeutics, Inc. Fused pyrimidines as d-alanyl-d-alanine ligase inhibitors
CN101163706A (zh) * 2005-04-21 2008-04-16 贝林格尔·英格海姆国际有限公司 用于治疗炎性疾病的二氢噻吩并嘧啶
AR059898A1 (es) * 2006-03-15 2008-05-07 Janssen Pharmaceutica Nv Derivados de 3-ciano-piridona 1,4-disustituida y su uso como moduladores alostericos de los receptores mglur2
EP1847543A1 (de) 2006-04-19 2007-10-24 Boehringer Ingelheim Pharma GmbH & Co. KG Dihydrothienopyrimidine zur Behandlung von entzündlichen Erkrankungen
TW200845978A (en) * 2007-03-07 2008-12-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
TW200900065A (en) 2007-03-07 2009-01-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
KR20100065191A (ko) 2007-09-14 2010-06-15 오르토-맥닐-얀센 파마슈티칼스 인코포레이티드 １,３-이치환된 ４-(아릴-ｘ-페닐)-１ｈ-피리딘-２-온
AU2008297877C1 (en) * 2007-09-14 2013-11-07 Addex Pharma S.A. 1,3-disubstituted-4-phenyl-1 H-pyridin-2-ones
DE602008004794D1 (de) * 2007-09-14 2011-03-10 Addex Pharmaceuticals Sa 1',3'-disubstituierte 4-phenyl-3,4,5,6-tetrahydro-2h,1'h-ä1,4'übipyridinyl-2'-one
RU2500681C2 (ru) * 2007-10-19 2013-12-10 Берингер Ингельхайм Интернациональ Гмбх Замещенные гетероциклом пиперазинодигидротиенопиримидины
US8486948B2 (en) 2007-10-19 2013-07-16 Boehringer Ingelheim International Gmbh Piperazinodihydrothienopyrimidine derivatives
EP2610258B1 (de) * 2007-10-19 2014-08-27 Boehringer Ingelheim International Gmbh Substituierte Piperidino-Dihydrothienopyrimidine
US8785486B2 (en) * 2007-11-14 2014-07-22 Janssen Pharmaceuticals, Inc. Imidazo[1,2-A]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors
EP2344470B1 (en) 2008-09-02 2013-11-06 Janssen Pharmaceuticals, Inc. 3-azabicyclo[3.1.0]hexyl derivatives as modulators of metabotropic glutamate receptors
CN102186477B (zh) 2008-10-16 2013-07-17 奥梅-杨森制药有限公司 作为代谢型谷氨酸受体调节剂的吲哚和苯并吗啉衍生物
CN102232074B (zh) 2008-11-28 2014-12-03 奥梅-杨森制药有限公司 作为代谢性谷氨酸盐受体调节剂的吲哚和苯并噁嗪衍生物
MY153913A (en) 2009-05-12 2015-04-15 Janssen Pharmaceuticals Inc 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
AR076861A1 (es) 2009-05-12 2011-07-13 Addex Pharma Sa Derivados de 1,2,4-triazolo (4,3-a)piridina y su uso como moduladores alostericos positivos de los receptores de mglur2
WO2010130422A1 (en) 2009-05-12 2010-11-18 Ortho-Mcneil-Janssen Pharmaceuticals, Inc 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
CA2814998C (en) 2010-11-08 2019-10-29 Janssen Pharmaceuticals, Inc. 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
US8993591B2 (en) 2010-11-08 2015-03-31 Janssen Pharmaceuticals, Inc. 1,2,4-triazolo[4,3-a] pyridine derivatives and their use as positive allosteric modulators of MGLUR2 receptors
ES2552455T3 (es) 2010-11-08 2015-11-30 Janssen Pharmaceuticals, Inc. Derivados de 1,2,4-triazolo[4,3-a]piridina y su uso como moduladores alostéricos positivos de receptores mGluR2
US20130059866A1 (en) 2011-08-24 2013-03-07 Boehringer Ingelheim International Gmbh Novel piperidino-dihydrothienopyrimidine sulfoxides and their use for treating copd and asthma
US9802954B2 (en) 2011-08-24 2017-10-31 Boehringer Ingelheim International Gmbh Piperidino-dihydrothienopyrimidine sulfoxides and their use for treating COPD and asthma
JO3368B1 (ar) 2013-06-04 2019-03-13 Janssen Pharmaceutica Nv مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2
JO3367B1 (ar) 2013-09-06 2019-03-13 Janssen Pharmaceutica Nv مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2
JP2016531870A (ja) * 2013-09-27 2016-10-13 ニンバス アイリス， インコーポレイテッド Ｉｒａｋ阻害剤およびその使用
PH12019500127B1 (en) 2014-01-21 2022-05-04 Janssen Pharmaceutica Nv Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use
SMT201900545T1 (it) 2014-01-21 2019-11-13 Janssen Pharmaceutica Nv Combinazioni comprendenti modulatori allosterici positivi o agonisti ortosterici del recettore glutammatergico metabotropico sottotipo 2 e loro utilizzo
CN106674132B (zh) * 2016-11-22 2019-04-26 上海书亚医药科技有限公司 一种嘧啶类除草剂的制备方法与应用
CN112569239B (zh) * 2020-12-18 2021-12-28 北京鑫开元医药科技有限公司 作为tlr8激动剂的药物组合物、其制备方法及其用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3650376A (en) * 1970-08-17 1972-03-21 Conveyor Systems Accumulating conveyor
GB1345524A (en) * 1970-09-30 1974-01-30 Lilly Industries Ltd N-heteroarylidene erythomycylamines
DE2515077A1 (de) * 1975-04-07 1976-10-28 Thomae Gmbh Dr K Neue 9-alkylidenamino-erythromycine, ihre salze und verfahren zu ihrer herstellung
DE2515075C2 (de) * 1975-04-07 1985-10-24 Dr. Karl Thomae Gmbh, 7950 Biberach Erythromycinderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DK139522C (da) * 1975-04-07 1979-08-20 Thomae Gmbh Dr K Analogifremgangsmaade til fremstilling af 9-iminoalkylamino-erythromyciner eller syreadditionssalte deraf

Also Published As

Publication number Publication date
ATA773178A (de) 1980-08-15
NZ188872A (en) 1981-05-29
IL55906A0 (en) 1979-01-31
NO783767L (no) 1979-05-11
ZA786313B (en) 1980-07-30
IT1109331B (it) 1985-12-16
EP0001981A1 (de) 1979-05-30
JPS5476588A (en) 1979-06-19
DE2860585D1 (en) 1981-04-23
GR65281B (en) 1980-08-01
AT361623B (de) 1981-03-25
EP0001981B1 (de) 1981-04-01
IT7851850A0 (it) 1978-11-09
DE2750288A1 (de) 1979-05-17
US4256738A (en) 1981-03-17
AU4144878A (en) 1979-05-17
DK499778A (da) 1979-05-11
CA1107726A (en) 1981-08-25
PT68771A (de) 1978-12-01
YU261178A (en) 1982-08-31
FI783417A7 (fi) 1979-05-11

Similar Documents

Publication Publication Date Title
ES474693A1 (es) Procedimiento para la preparacion de 9-(w-heteroarilamino-alcohilamino)-eritromicinas.
IL86013A (en) N,n-disubstituted-1h-pyrazolo(3,4-d)pyrimidin-4-amines,processes for the preparation thereof and pharmaceutical compositions containing them
ES8308327A1 (es) Un procedimiento para la preparacion de nuevos derivados biciclicos de piridin-5-ona.
NO179906C (no) Fremgangsmåte for fremstilling av hydroksymetyl(metylencyklopentyl) puriner og -pyrimidiner
HK25884A (en) Pyridopyrimidines
AU547792B2 (en) Pyrimido(5,4-d)pyrimidines
AR217668A1 (es) Procedimiento de preparacion de derivados de tetrahidro-4,5,6,7-tieno-(2,3-c)-y-(3,2-c)-piridinas,utilizables como medicamentos
ES370107A1 (es) Procedimiento para la obtencion de derivados de pirimidina.
ES8706682A1 (es) Metodo para la fabricacion de nuevas triazolopirimidinas.
GB2007656A (en) 4-amino-2-(piperazin-1-yl or homopiperazin-1-yl) quinazoline derivatives
FR2386547A1 (fr) Nouveaux derives de la pyrido-(2,3-b)benzothiazepine-(1,5) substitues en position 5, leur procede de preparation et leur application pharmaceutique
BR8706931A (pt) Amidas de acido 6,7-dihidro-1,2,4 triazolo 1,5-a 1,3,5,triazino-2-sulfonico,processo para sua preparacao,composicao com efeito herbicida e regulador do crescimento,emprego e processo para a preparacao de composicoes
US4026893A (en) Pyrazolo{8 1,5-a{9 pyrido{8 3,2-e{9 pyrimidine-7-carboxylic acid derivatives
FR2382452A1 (fr) 3, 7-dihydro- et 1, 7-dihydro-4h-pyrazolo (4', 3':5, 6) pyrido (4, 3-d) pyrimidin-4-ones et leur utilisation comme medicaments
ES8300116A1 (es) Procedimiento para la obtencion de nuevos derivados de la tiazolo (3,2-a)pirimidina
AU520803B2 (en) Pyrido (1,2-a) pyrimidine derivatives
ATE147075T1 (de) Purinverbindungen, verfahren zu ihrer herstellung, pharmazeutische präparate und zwischenverbindungen
JPS5318600A (en) Pyrido (2,3-d) pyrimidine derivatives and their preparaion
JPS5353695A (en) Preparation of pyrimido 5,4-d pyrimidine derivatives
NISHIGAKI et al. Synthesis of [1, 2, 3] Thiadiazolo [5, 4-d] pyrimidines
JPS5259192A (en) Preparation of 2,6-bis(diethanolamino)_4,8-dipiperidino-pyrimido 5,4-d pyrimidines
JPS51143697A (en) A process for preparing novel pyrimido (4,5-d) pyrimidine derivatives
DE69026638D1 (de) Verfahren zur Herstellung von Pyrido[1,2-a]pyrimidinderivaten
JPS5353698A (en) Pyrrolotriazolopyrimidine derivatives and their preparation
FR2375237A1 (fr) Procede de preparation d'isoxazolo(3,4-d)pyrimidines et leur composition therapeutique